AERI - Aerie Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Aerie Pharmaceuticals's activity chart (see below) currently has 192 price targets and 141 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.39% with an average time for these price targets to be met of 175.51 days.

Most recent stock forecast was given by from CITI on 29-Aug-2022. First documented stock forecast 19-Mar-2014.

Best performing analysts who are covering AERI - Aerie Pharmaceuticals:

Adnan Butt Corey Davis Difei Yang Annabel Samimy Elliot Wilbur

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Dec-2019

$13

4 years 1 months 8 days ago
(29-Aug-2022)

1/6 (16.67%)

$4.7 (56.63%)

176

Buy Since 07-Nov-2019

$20

4 years 1 months 13 days ago
(24-Aug-2022)

0/5 (0%)

$14.21 (245.42%)

Buy Since 09-Jan-2020

$29

4 years 1 months 13 days ago
(24-Aug-2022)

0/2 (0%)

$14.55 (100.69%)

Buy Since 17-Sep-2015

$14

4 years 1 months 14 days ago
(23-Aug-2022)

7/19 (36.84%)

$7.75 (124.00%)

211

Buy Since 22-Oct-2019

$15.25

$62

4 years 1 months 14 days ago
(23-Aug-2022)

1/2 (50%)

$0.09 (0.59%)

48

Show more analysts

Please expand the browser size to see the chart

What is AERI (Aerie Pharmaceuticals) average time for price targets to be met?

On average it took 176 days for the stock forecasts to be reached, with an average price target met ratio of 40.39%.

Which analyst most recently updated their price target on AERI (Aerie Pharmaceuticals)?

Which analyst has the most public recommendations on AERI (Aerie Pharmaceuticals)?

has 0 price targets and 0 ratings on AERI

Which analyst is the currently most bullish on AERI (Aerie Pharmaceuticals)?

Tyler Van Buren with the highest potential upside of $84.75

Which analyst is the currently most reserved on AERI (Aerie Pharmaceuticals)?

Jason Gerberry with the lowest potential downside of -$6.25
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?